Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays.
作者信息
Murray Patrick, Cooper Charles, Maus Courtney
机构信息
Scientific Affairs, BD Life Sciences, Franklin Lakes, New Jersey, USA
Medical Affairs, BD Life Sciences, Franklin Lakes, New Jersey, USA.
出版信息
J Clin Microbiol. 2019 Aug 26;57(9). doi: 10.1128/JCM.00779-19. Print 2019 Sep.
Abstract
摘要
相似文献
1
Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays.BD MAX耐多药结核病检测与赛沛Xpert MTB/RIF检测的性能比较
J Clin Microbiol. 2019 Aug 26;57(9). doi: 10.1128/JCM.00779-19. Print 2019 Sep.
2
Reply to Murray et al., "Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays".对默里等人《BD MAX耐多药结核病检测与赛沛Xpert MTB/RIF检测的性能比较》一文的回复
J Clin Microbiol. 2019 Aug 26;57(9). doi: 10.1128/JCM.00984-19. Print 2019 Sep.
3
Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study.中国武汉使用Xpert MTB/RIF检测利福平耐药和耐多药结核病：一项回顾性研究
Microb Drug Resist. 2018 Jun;24(5):675-679. doi: 10.1089/mdr.2017.0114. Epub 2017 Oct 20.
4
Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.在埃塞俄比亚西南部，使用Xpert MTB/RIF快速检测肺结核患者中耐利福平的结核分枝杆菌。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S48-S49. doi: 10.1016/j.ijmyco.2016.09.002. Epub 2016 Nov 5.
5
Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania: a retrospective cohort study.坦桑尼亚基于 Xpert MTB/RIF 检测的依赖对治疗时间和耐多药结核病治疗结局的影响：一项回顾性队列研究。
Int Health. 2019 Nov 13;11(6):520-527. doi: 10.1093/inthealth/ihz005.
6
A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB.一种临床前验证计划，用于评估分子诊断学的分析灵敏度，如 BD MAX MDR-TB、Xpert MTB/Rif Ultra 和 FluoroType MTB。
PLoS One. 2020 Jan 7;15(1):e0227215. doi: 10.1371/journal.pone.0227215. eCollection 2020.
7
Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.与TaqMan MTB和TRC快速结核分枝杆菌检测法相比，Xpert MTB/RIF在中等结核病发病率地区的性能评估
J Infect Chemother. 2017 Feb;23(2):101-106. doi: 10.1016/j.jiac.2016.11.004. Epub 2016 Dec 3.
8
Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.Xpert MTB/RIF检测在福尔马林固定、石蜡包埋组织中诊断结核病的性能。
Int J Mycobacteriol. 2017 Jan-Mar;6(1):87-93. doi: 10.4103/2212-5531.201892.
9
Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.在低发病率、高资源环境下，Xpert MTB/RIF检测用于诊断肺结核和利福平耐药性的性能。
PLoS One. 2017 Oct 9;12(10):e0186139. doi: 10.1371/journal.pone.0186139. eCollection 2017.
引用本文的文献
1
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.Xpert MTB/XDR 检测系统用于检测肺结核病及异烟肼、氟喹诺酮类、乙胺丁醇和阿米卡星耐药性。
Cochrane Database Syst Rev. 2022 May 18;5(5):CD014841. doi: 10.1002/14651858.CD014841.pub2.
2
The Performance of the Abbott Real Time MTB RIF/INH Compared to the MTBDR V2 for the Identification of MDR-TB Among Isolates.将雅培实时MTB RIF/INH与MTBDR V2在鉴定分离株中的耐多药结核病方面的性能进行比较。
Infect Drug Resist. 2020 Sep 28;13:3301-3308. doi: 10.2147/IDR.S247524. eCollection 2020.
3
Reply to Murray et al., "Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays".对默里等人《BD MAX耐多药结核病检测与赛沛Xpert MTB/RIF检测的性能比较》一文的回复
J Clin Microbiol. 2019 Aug 26;57(9). doi: 10.1128/JCM.00984-19. Print 2019 Sep.
本文引用的文献
1
GeneXpert MTB/RIF Is Superior to BBD Max MDR-TB for Diagnosis of Tuberculosis (TB) in a Country with Low Incidence of Multidrug-Resistant TB (MDR-TB).在多重耐药结核病（MDR-TB）发病率较低的国家，GeneXpert MTB/RIF在结核病（TB）诊断方面优于BBD Max MDR-TB。
J Clin Microbiol. 2019 May 24;57(6). doi: 10.1128/JCM.00537-19. Print 2019 Jun.
2
The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study.提高对异烟肼耐药结核病的检测和治疗水平对耐多药结核病流行率的影响：建模研究。
PLoS One. 2019 Jan 24;14(1):e0211355. doi: 10.1371/journal.pone.0211355. eCollection 2019.
3
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.在一个耐药结核病发病率较低的国家，表型上对利福平敏感的结核分枝杆菌分离株中出现有争议的 rpoB 突变。
BMC Infect Dis. 2019 Jan 3;19(1):3. doi: 10.1186/s12879-018-3638-z.
4
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis.一线药物治疗耐异烟肼结核病：系统评价和荟萃分析。
Lancet Infect Dis. 2017 Feb;17(2):223-234. doi: 10.1016/S1473-3099(16)30407-8. Epub 2016 Nov 17.
5
Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005.1996 - 2005年科威特结核分枝杆菌分离株药敏模式的长期趋势
Int J Tuberc Lung Dis. 2008 Mar;12(3):319-25.
Zotero 插件